Text Size
1823 studies found for:    Pulmonary Disease, Chronic Obstructive: Clinical Trials

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
Pulmonary Disease, Chronic Obstructive: Clinical Trials (1823 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).
Conditions: COPD;   Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Collection of safety data for Cohort 1
2 Completed A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GW685698/GW642444
3 Completed Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Osteoporosis;   Chronic Obstructive Pulmonary Disease (COPD);   Osteopenia
Interventions: Drug: fluticasone propionate/salmeterol powder;   Drug: salmeterol powder
4 Completed Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Prednisolone
5 Recruiting Spontaneous Breathing Trials Using Pressure-Support or T-Tube in Chronic Obstructive Pulmonary Disease Patients Weaning Mechanical Ventilation
Conditions: Weaning of Mechanical Ventilation;   Chronic Obstructive Pulmonary Disease
Interventions: Procedure: "T" Tube Spontaneous Breathing Trial;   Procedure: Pressure Support Ventilation
6 Recruiting Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Cardiovascular Disease
Interventions: Drug: fluticasone furoate/vilanterol;   Drug: fluticasone furoate;   Drug: vilanterol;   Other: Placebo
7 Enrolling by invitation European Quality of Care Pathways Study on Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Other: COPD evidence based care pathway
8 Completed A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 Days
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GSK573719
9 Active, not recruiting The Chronic Obstructive Pulmonary Disease Fish Oil Pilot Trial
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Dietary Supplement: n-3 polyunsaturated fatty acids;   Other: Placebo
10 Completed 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK573719/GW642444 125/25;   Drug: GSK573719/GW642444 62.5/25;   Drug: GSK573719;   Drug: tiotropium bromide
11 Completed Long-term Safety Study for GSK573719/GW642444 in Japanese
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GSK573719/GW642444 Inhalation Powder
12 Completed
Has Results 		Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Formoterol (OT)
13 Completed Study to Investigate Daily Symptom Variability, Symptom Effects on Morning Activities of Chronic Obstructive Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
14 Completed Discharge Coordinator Intervention in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: Coordinated discharge;   Other: Control
15 Not yet recruiting A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Umeclidinium bromide/Vilanterol;   Drug: Placebo ACCUHALER/DISKUS;   Drug: Fluticasone propionate/Salmeterol;   Drug: Placebo NDPI
16 Terminated
Has Results 		A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD
Conditions: Diabetes Mellitus;   Chronic Obstructive Pulmonary Disease
Interventions: Drug: Subcutaneous Insulin;   Drug: Inhaled Insulin
17 Completed A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: 125/25 mcg once-daily;   Drug: 125mcg once-daily;   Drug: Placebo once-daily
18 Completed GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: fluticasone propionate/salmeterol combination DISKUS
19 Completed SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Tiotropium bromide 18mcg;   Drug: Fluticasone propionate/ salmeterol combination 50/500mcg
20 Recruiting Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
Conditions: Pulmonary Hypertension;   Chronic Obstructive Pulmonary Disease
Interventions: Drug: Inhaled nitric oxide;   Other: Placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years